Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

BACKGROUND: Median survival of non-small cell lung cancer (NSCLC) patients with brain metastases is poor. We examined concurrent erlotinib and whole brain radiotherapy (WBRT) followed by maintenance erlotinib in patients with untreated brain metastases, given the potential radiosensitizing propertie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Siow Ming, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Ngai, Yenting, Hackshaw, Allan, Faivre-Finn, Corinne
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://ncbi.nlm.nih.gov/pubmed/25031274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju151
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak